Skip to content

Kathleen Mary Devine, M.D.

NPI 1831380435ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Washington, DC

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Washington, District of Columbia, licensed in DC and MD, with an NPI issued in August 2007. Ferring Pharmaceuticals As was the largest of 5 companies reporting payments in 2025, $43,906 in all, mostly consulting fees.

Overview

NPI1831380435
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedAug 8, 2007
Last updated in NPPESApr 25, 2016

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$43,906 · 19 payments from 5 companies
  • 2024$6,662 · 7 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$31,574 · 4 payments
  • Travel and Lodging$11,351 · 4 payments
  • Food and Beverage$980.44 · 11 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Washington

All Obstetrics & Gynecology, Reproductive Endocrinology providers in District of Columbia →